Q32 Bio Inc.
QTTB
$6.25
-$0.05-0.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.82M | -42.10M | -52.30M | -59.79M | -47.73M |
| Total Depreciation and Amortization | 391.00K | 421.00K | 453.00K | 483.00K | 487.00K |
| Total Amortization of Deferred Charges | 180.00K | 192.00K | 196.00K | 213.00K | 194.00K |
| Total Other Non-Cash Items | -59.90M | 5.57M | 5.41M | 4.74M | -11.03M |
| Change in Net Operating Assets | -4.04M | -2.87M | -7.84M | -11.29M | -9.64M |
| Cash from Operations | -33.54M | -38.79M | -54.08M | -65.65M | -67.72M |
| Capital Expenditure | -- | -2.00K | -60.00K | -75.00K | -75.00K |
| Sale of Property, Plant, and Equipment | 7.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 10.00M | 19.90M | 20.00M |
| Cash from Investing | 7.00M | -2.00K | 9.94M | 19.83M | 19.93M |
| Total Debt Issued | -- | 0.00 | -53.16M | 0.00 | 7.00M |
| Total Debt Repaid | -3.13M | -1.56M | 8.71M | 0.00 | 0.00 |
| Issuance of Common Stock | -- | 317.00K | 1.31M | 1.69M | 43.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 44.44M | -5.90M | 44.44M |
| Cash from Financing | -3.13M | -1.25M | 1.31M | -4.21M | 95.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.67M | -40.04M | -42.83M | -50.03M | 47.35M |